Question

What is the success rate of stem cell therapy for Stroke Recovery?

No universal success rate exists. Review stroke type and time since event, exact product and route, randomised comparator, blinded validated motor, language, cognitive and daily-function outcomes, mortality, recurrent stroke, serious adverse events and complete follow-up.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

What the evidence shows for Stroke Recovery

Recovery varies with stroke type, location, size, time, complications and rehabilitation. Early-phase cell studies primarily assess feasibility and safety; uncontrolled functional change cannot separate the product from spontaneous recovery and rehabilitation. The NINDS stroke-recovery guide identifies rehabilitation as central to recovery, while the FDA consumer alert states that the promoted regenerative products it addresses are not approved in the United States to treat stroke.

Am I a candidate? → · Stroke Recovery: full overview → · Stroke Recovery cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information